Not Exactly ‘Pay for Performance’ for These Big Pharma CEOs

by Melly Alazraki on Mar.03, 2011, under Towing

Most workers would worry about losing their jobs, let alone receiving a bonus, if they slacked off, but CEOs are held to a different standard. For example, despite several stumbles, GSK’s CEO got a nice bonus, and J&J’s CEO even got a raise for a job badly done.

Continue reading Not Exactly ‘Pay for Performance’ for These Big Pharma CEOs

Not Exactly ‘Pay for Performance’ for These Big Pharma CEOs originally appeared on DailyFinance on Thu, 03 Mar 2011 17:00:00.

Filed Under: Company News, Columns, People, Health Care, Johnson & Johnson, GlaxoSmithKline, Stocks in the News